Search Results
Products
MSD Animal Health is committed to protecting the health of animals and supporting a safe and affordable food supply. Through our broad portfolio of vaccines, therapeutic medicines, parasiticides, and technology solutions, we help veterinarians, pet owners, farmers, and producers maintain and improve the health of animals.
News Releases
Mexico’s SADER Approves MSD Animal Health’s BRAVECTO® (Fluralaner) Chew Tableta Masticable (Chew) for the Treatment of New World Screwworm (Cochliomyia hominivorax) in Dogs
MSD Animal Health, a division of MSD & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced Mexico’s SADER granted approval for BRAVECTO® (Fluralaner) Chew Tableta Masticable (Chew) for the treatment of infestations caused by New World screwworm (Cochliomyia hominivorax) larvae (myiasis).
News Releases
European Commission Grants Marketing Authorization for NOBIVAC NXT HCPChFeLV from MSD Animal Health
MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the U.S. Food and Drug Administration (FDA) has granted a conditional approval for EXZOLT™ CATTLE-CA1 (fluralaner topical solution). This innovative product is in the newest class of parasiticides known as isoxazolines.
News Releases
Study from MSD Animal Health Reveals Opportunity to Increase Feline Vaccination through Knowledge Sharing Between Veterinarians and Cat Owners
MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the publication of results from a recent global survey of cat owners and veterinarians aimed at uncovering key drivers, barriers and unmet needs affecting feline vaccination compliance. The study, “Drivers, Barriers, and Unmet Needs affecting Feline Vaccination Compliance: Insights from a Global Survey of Cat Owners and Veterinarians,” was presented at the 2026 World Feline Congress 2026 June 26-28, 2026 and published in the journal Veterinary Sciences.
News Releases
Study Reveals Dog Owners and Veterinarians See Challenges in Treating Allergic Skin Disease, Highlighting a Need for a Targeted Rapid Onset Treatment for Dogs of All Ages
MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the U.S. Food and Drug Administration (FDA) has granted a conditional approval for EXZOLT™ CATTLE-CA1 (fluralaner topical solution). This innovative product is in the newest class of parasiticides known as isoxazolines.
News Releases
MSD Animal Health to Acquire TARGAN
MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced a comprehensive scientific review of dairy cattle parasites has revealed that “hidden” infections are costing the global cattle industry billions of dollars every year.
News Releases
New Research from MSD Animal Health Reveals “Hidden” Parasitic Infections Cost Global Dairy Industry Billions Each Year
MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced a comprehensive scientific review of dairy cattle parasites has revealed that “hidden” infections are costing the global cattle industry billions of dollars every year.
News Releases
FDA Approves NUMELVI™ (atinvicitinib tablets) for Dogs from MSD Animal Health – The First and Only Second-Generation Janus Kinase (JAK) Inhibitor for the Control of Pruritus Associated with Allergic Dermatitis
MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the U.S. Food and Drug Administration (FDA) has granted a conditional approval for EXZOLT™ CATTLE-CA1 (fluralaner topical solution). This innovative product is in the newest class of parasiticides known as isoxazolines.
News Releases
MSD Animal Health Wins 2025 S&P Global Award in Best Product Companion Animal and Best Product Food Animal Categories for NUMELVI and INNOVAX® ND-IBD-ILT, Respectively
S&P Global Animal Health awarded NUMELVI® Best Companion Animal Product and INNOVAX® ND-ILT-IBD Best Food Animal Product. This is the 8th consecutive year that MSD Animal Health earned an S&P Global Award and the first time a company has won the Best Product Companion Animal and Best Product Food Animal awards in the same year.
News Releases
MSD Animal Health and FVE Reward 34 Veterinary Students from Across Europe
MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the U.S. Food and Drug Administration (FDA) has granted a conditional approval for EXZOLT™ CATTLE-CA1 (fluralaner topical solution). This innovative product is in the newest class of parasiticides known as isoxazolines.
Allflex Livestock Intelligence
Allflex Livestock Intelligence is the global leader in the design, development, manufacture and delivery of animal identification and monitoring devices.
Companion Animal
State-of-the-art products and services that help pets live longer, healthier lives.